Suchergebnisse - "Kirk, Allison M"

PubPharm (7)

1

DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma

enthalten in: Cell reports. Medicine | 2024

von Kirk, A. | Crawford, J. | Chou, C. | +35

2

Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2

enthalten in: Scientific reports | 2023

von Roubidoux, E. | Brigleb, P. | Vegesana, K. | +31

UpdateOf: bioRxiv. 2023 Jul 13;:. - PMID 37503213

3

Host Predictors of Broadly Cross-Reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Differ Between Infection and Vaccination

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Tang, L. | Cherry, S. | Tuomanen, E. | +37

4

SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells

enthalten in: Nature immunology | 2022

von Minervina, A. | Pogorelyy, M. | Kirk, A. | +50

UpdateOf: medRxiv. 2022 Jan 26;:. - PMID 34341799

5

SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans

enthalten in: Cell | 2022

von Mudd, P. | Minervina, A. | Pogorelyy, M. | +59

6

Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response

enthalten in: Cell host & microbe | 2022

von Lin, C. | Wolf, J. | Brice, D. | +50

7

Cross-reactive Antibody Response to mRNA SARS-CoV-2 Vaccine After Recent COVID-19-Specific Monoclonal Antibody Therapy

enthalten in: Open forum infectious diseases | 2021

von Schultz-Cherry, S. | McGargill, M. | Thomas, P. | +35

1
[1]